Drug Index


Mechanism :

It is a triazole-derivative antiepileptic whose exact mechanism is unknown. It is known to prolong the inactive state of the sodium channels.

Indication :

  • Lennox-Gastaut syndrome: As an adjunctive treatment

Contraindications :

Patients with familial short QT syndrome; hypersensitivity to rufinamide, triazole derivatives, or any component of the formulation.

Dosing :

10 mg/kg/day PO in 2 equally divided doses; increase dose by ~10 mg/kg every other day to a maximum dose of 45 mg/kg/day, not to exceed 3,200 mg daily in 2 equally divided doses.

Adverse Effect :

Shortened QT interval, ataxia, aggressive behaviour, hyperactivity, headache, drowsiness, fatigue, vomiting, nausea, skin rash, decreased appetite, leukopenia, anemia, diplopia, blurred vision.

Interaction :

Alcohol (Ethyl): May enhance the adverse/toxic effect of Rufinamide. Specifically, sleepiness and dizziness may be enhanced.
Carbamazepine: Rufinamide may decrease the serum concentration of Carbamazepine and vice-versa.
CNS Depressants: Rufinamide may enhance the adverse/toxic effect of CNS Depressants.
Valproate Products: May increase the serum concentration of Rufinamide.

Hepatic Dose :

Mild to moderate hepatic impairment: Dose reduction may be needed.
Severe hepatic impairment: Use is not recommended.
02/14/2024 21:12:31 Rufinamide
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0